Related Experiment Videos
[Peripheral blood stem cell transplantation: present status and future prospects]
1Department of Pediatrics, University of Tokushim.
Summary
Autologous peripheral blood stem cell transplantation (PBSCT) offers faster recovery and fewer complications than marrow transplantation. This review highlights its effectiveness and growing use in treating leukemia and other conditions.
Area of Science:
- Hematology
- Oncology
- Transplantation Medicine
Context:
- Autologous peripheral blood stem cell transplantation (PBSCT) is an alternative to traditional bone marrow harvesting.
- PBSC collection is less invasive, avoiding anesthesia and reducing complications.
- The procedure facilitates high-dose therapy administration in diverse hospital settings.
Purpose:
- To provide a comprehensive review of autologous PBSCT.
- To compare autologous PBSCT with marrow transplantation and allogeneic bone marrow transplantation.
- To discuss the current and potential applications of PBSC.
Summary:
- Autologous PBSCT demonstrates rapid hematopoietic recovery and fewer complications compared to marrow transplantation.
- Therapeutic outcomes in relapsed childhood acute lymphoblastic leukemia are comparable to allogeneic bone marrow transplantation.
- PBSC is increasingly utilized post-consolidation therapy and investigated for allogeneic applications.
Impact:
- PBSCT enables safer high-dose therapy, expanding treatment accessibility.
- Equivalent efficacy to allogeneic transplantation in certain leukemias broadens therapeutic options.
- Standardization of PBSC collection, processing, and storage is anticipated in major blood centers.